PUBLISHER: Polaris Market Research | PRODUCT CODE: 1943062
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1943062
The global Next-Generation Sequencing market size is expected to reach USD 34.47 billion by 2034, according to a new study by Polaris Market Research. The report "Next-Generation Sequencing Market Share, Size, Trends, & Industry Analysis Report By Application (Drug Discovery/Personalized Medicine, Genetic Screening, Diagnostics/Infectious Diseases); By Technology; By Product; By End-Use; By Region; Segment Forecast, 2026-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Next-generation sequencing (NGS) is a highly parallelized process characterized by its ultra-high throughput, scalability, and fast rate in determining the sequence of nucleotides across the entire genome. DNA pre-sequencing is a crucial step in the general sequencing protocol because it involves preparing the material for the subsequent sequencing reaction. The NGS market is competitive and includes several major players, multinational corporations, and smaller regional manufacturers. These companies engage in research and development activities to introduce innovative stent designs and materials that improve performance and patient outcomes.
Pediatrix Medical Group, GeneDx Inc., and OPKO Health, for instance, agreed to provide advanced next-gen eration gene sequencing in August 2020. This partnership aims to enhance clinical diagnosis of rare disorders in intensive care units for newborns. The next-generation sequencing market also witnessed a rise in partnerships and acquisitions between sequencing technology companies and pharmaceutical or biotechnology firms. These collaborations aimed to use genomic data for drug discovery, development, and the realization of precision medicine initiatives. Also, cloud-based solutions for next-generation sequencing data storage and analysis were becoming more popular, allowing researchers to manage and analyze large-scale genomic data more efficiently. It corresponded to the growing emphasis on data management and bioinformatics solutions to deal with the massive amounts of data generated by next-generation sequencing platforms.
The reagents and consumables segment held the largest revenue share in 2025. The dominance is attributed to an evolution in molecular genetics and increasing demand for products and kits that accomplish size selection, target enrichment, and DNA fragmentation.
The services segment witnessed the fastest market growth in 2025. The growth is driven by advancements in the technology based on SMRT sequencing and surging application of cloud computing for NGS data storage.
In 2025, North America accounted for the largest market share. Technological advancements in sequencing platforms and the surge in NGS applications in the region boost the regional market growth. The government support and the surging prevalence of cancer will also drive the market's growth.
The Asia Pacific next generation sequencing market is expected to witness the fastest growth during the forecast period. The growth is fueled by the increasing investments in China and India in the research and development of NGS.
A few global key market players include BGI, Bio-Rad Laboratories, Inc., DNASTAR, Inc., Eurofins GATC Biotech GmbH, Genomatix GmbH, Oxford Nanopore Technologies, PerkinElmer, Inc., PierianDx, Qiagen, Roche Ltd., and Thermo Fisher Scientific Inc.
Where is Next Generation Sequencing Market Headed?
The next-generation sequencing market is anticipated to grow in the coming years owing to increased use in clinical diagnosis. Improvements in speed, cost-effectiveness, and accuracy will also boost the growth. Additionally, the improved efficiency over traditional technologies such as microarrays and an increasing number of drug discovery applications will contribute to the industry growth. Furthermore, the market is expected to grow as NGS technologies become more widely used in clinical diagnostics. These technologies' quick response times and enhanced processing capabilities create a favorable environment for market growth.
What Next Generation Sequencing Report Reveals?
What is the global market size, growth trend, and CAGR for the market through 2034?
What are the factors driving and restraining the market growth?
What is the impact of regulatory landscape on the NGS market?
Who are the key players, and what is their relative position in terms of competitive positioning?
Why to Invest in the next generation sequencing (NGS) market?
How does the demand for different products influence the market landscape?
How does the market differ in application, technology, product, end-use, and geography, and which is the leading application?
What are the trends in the regions of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa?
Polaris Market Research has segmented the next-generation sequencing market report based on application, technology, product, end-use, and region.
By Application Outlook (Revenue - USD Billion, 2021-2034)
Drug Discovery/Personalized Medicine
Genetic Screening
Diagnostics/Infectious Diseases
Agricultural & Animal Research
Others
By Technology Outlook (Revenue - USD Billion, 2021-2034)
Whole Genome Sequencing
Targeted Sequencing & Re-sequencing
Whole Exome Sequencing
RNA Sequencing
Chip Sequencing
De Novo Sequencing
Methyl Sequencing
By Product Outlook (Revenue - USD Billion, 2021-2034)
Instruments
Reagents & Consumables
Services
By End-Use Outlook (Revenue - USD Billion, 2021-2034)
Healthcare Institutions
Academics
Biotech & Pharma Firms
Others